FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

Researchers evaluated vascular samples from more than 200 mummies, presenting their findings in European Heart Journal.

The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms. 

CT calcium scoring provides valuable evaluations of intermediate-risk patients in addition to making good business sense for hospitals. Nauman Mushtaq, MD, an interventional cardiologist with Northwestern, shared his own experience with this technology. 

One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.

Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.

Leslee Shaw, PhD, director of the Blavatnik Family Women's Health Research Institute, a professor of medicine at the Icahn School of Medicine at Mount Sinai, and a former president of both SCCT and ASNC, explains the sex differences in cardiovascular imaging presentations in women versus men.